Resolution of gastrointestinal protein loss after Helicobacter pylori eradication in a patient with hypertrophic lymphocytic gastritis

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Ahmed Madisch - , Universitätsklinikum Carl Gustav Carus Dresden, Medizinische Klinik und Poliklinik I (Autor:in)
  • Daniela Aust - , Institut für Pathologie, Universitätsklinikum Carl Gustav Carus Dresden (Autor:in)
  • Andrea Morgner - , Universitätsklinikum Carl Gustav Carus Dresden, Medizinische Klinik und Poliklinik I (Autor:in)
  • Dana Grossmann - , Universitätsklinikum Carl Gustav Carus Dresden, Medizinische Klinik und Poliklinik I (Autor:in)
  • Renate Schmelz - , Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus Dresden (Autor:in)
  • Joachim Kropp - , Universitätsklinikum Carl Gustav Carus Dresden, Klinik und Poliklinik für Nuklearmedizin (Autor:in)
  • Gerhard Ehninger - , Universitätsklinikum Carl Gustav Carus Dresden, Medizinische Klinik und Poliklinik I (Autor:in)
  • Gustavo Baretton - , Institut für Pathologie, Universitätsklinikum Carl Gustav Carus Dresden (Autor:in)
  • Stephan Miehlke - , Universitätsklinikum Carl Gustav Carus Dresden, Medizinische Klinik und Poliklinik I (Autor:in)

Abstract

Background. Lymphocytic gastritis is a rare condition found in approximately 1% of dyspeptic patients. An association with Helicobacter pylori infection has been described. Hypertrophic lymphocytic gastritis is a rare cause of gastrointestinal protein loss. Here, we describe a patient with hypertrophic lymphocytic gastritis, in whom gastrointestinal protein loss resolved completely following H. pylori eradication. Case Report. A 38-year old obese man without gastrointestinal symptoms showed a markedly decreased serum protein (53 g/l, normal 66-85 g/l), a decreased serum albumin (33 g/l, normal 35-52 g/l) and decreased serum immunoglobulin G and immunoglobulin M levels. A renal cause for protein loss was excluded, liver function was normal. Endoscopy of the upper gastrointestinal tract revealed enlarged rigid gastric folds, and an H. pylori-associated lymphocytic gastritis. 99mTc-labelled albumin scintigraphy showed an increased activity in the upper left abdomen compatible with protein secretion in the stomach, and tracer pooling in the upper small bowel. Push enteroscopy with histology demonstrated a normal upper small bowel. Two months after eradication therapy, cure of H. pylori infection was documented and serum protein (71 g/l) and albumin (41 g/l) had returned to normal, while lymphocytic gastritis was still present. One year after eradication therapy endoscopy of the upper gastrointestinal tract and histology and laboratory values were normal. Conclusion. Protein-losing gastropathy caused by H. pylori-associated hypertrophic lymphocytic gastritis can be cured solely by H. pylori eradication therapy.

Details

OriginalspracheEnglisch
Seiten (von - bis)629-631
Seitenumfang3
FachzeitschriftHelicobacter
Jahrgang9
Ausgabenummer6
PublikationsstatusVeröffentlicht - 2004
Peer-Review-StatusJa

Externe IDs

PubMed 15610076

Schlagworte

Ziele für nachhaltige Entwicklung

Schlagwörter

  • Helicobacter pylori, Hypertrophic lymphocytic gastritis, Protein-losing gastropathy